Bibliographic Details
| Title: |
Adjunctive linezolid versus clindamycin for toxin inhibition in β-lactam-treated patients with invasive group A streptococcal infections in 195 US hospitals from 2016 to 2021: a retrospective cohort study with target trial emulation |
| Authors: |
Adjemian, Jennifer, Baggs, James, Cox, Edward, Danner, Robert L, Dekker, John, Farley, John, Fiore, Anthony, Hooper, David, Jernigan, John, Jessup, Amber, Kadri-Rodriguez, Sameer, Klein, Eili, Klompas, Michael, Lai, Elaine, Laxminarayan, Ramanan, Palmore, Tara, Powers, John H, Prevots, D. Rebecca, Rhee, Chanu, Ricotta, Emily, Srinivasan, Arjun, Strich, Jeffrey R, Suffredini, Anthony, Babiker, Ahmed a, b, †, **, Warner, Sarah c, d, †, Li, Xiaobai e, Chishti, Emad A c, d, Saad, Eltaib g, Swihart, Bruce J c, d, Dekker, John P f, h, Walker, Morgan c, d, Lawandi, Alexander c, h, i, Kadri, Sameer S c, d, * |
| Source: |
In The Lancet Infectious Diseases March 2025 25(3):265-275 |
| Database: |
ScienceDirect |
